Bio-Techne Corp TECH

NAS: TECH | ISIN: US09073M1045 1/07/2025

52,08 USD (+1,22%)

(+1,22%) 1/07/2025

Grafiek Bio-Techne Corp

Grafiek Bio-Techne Corp

1 dag1d 1,22%
1 week1w 0,37%
1 maand1m 7,14%
3 maanden3m -10,79%
6 maanden6m -27,14%
1 jaar1j -26,90%
5 jaar5j -22,61%

Bio-Techne Corp in het nieuws

Toon enkel gratis nieuws

14 mei 2025 · ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) · Persbericht

12 mei 2025 · Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 · Persbericht

8 mei 2025 · Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing · Persbericht

8 mei 2025 · Bio-Techne to Present at the BofA Securities 2025 Health Care Conference · Persbericht

7 mei 2025 · Bio-Techne Declares Dividend And New Share Repurchase Program · Persbericht

7 mei 2025 · Bio-Techne Releases Third Quarter Fiscal 2025 Results · Persbericht

6 mei 2025 · ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. · Persbericht

29 april 2025 · ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy · Persbericht

24 april 2025 · Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection · Persbericht

23 april 2025 · Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting · Persbericht

Profiel Bio-Techne Corp

Gezondheidstechnologie

Productie van biologische producten

Website: www.bio-techne.com

Hoofdzetel: Minneapolis, Minnesota Verenigde Staten

CEO: Charles Kummeth

Werknemers: 1.595

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe